Related Experiment Video
Updated: Jun 18, 2025

Examining the Dynamics of Cellular Adhesion and Spreading of Epithelial Cells on Fibronectin During Oxidative Stress
Published on: October 13, 2019
Unheralded Adrenergic Receptor Signaling in Cellular Oxidative Stress and Death
Lilly Underwood1, Chun-Sun Jiang1, Joo-Yeun Oh1
1Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL.
Catecholamines (CAs) activate adrenergic receptors (ARs), impacting heart function. Understanding CA toxicity via ARs is vital for developing new heart failure treatments.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Pharmacology
Background:
- Catecholamines (CAs) are crucial for cardiac adaptation but prolonged high levels cause cardiovascular damage, leading to heart failure (HF).
- Adrenergic receptors (ARs) mediate key inotropic and chronotropic effects, but their role in CA-induced toxicity and cell death is increasingly recognized.
- Understanding the specific roles of alpha1-AR (α1AR) and beta-AR (βAR) in cardiac remodeling and survival is essential.
Purpose of the Study:
- To elucidate the complex signaling pathways of ARs in the context of catecholamine toxicity.
- To highlight the involvement of α1AR and βAR in cardiac remodeling and cellular survival mechanisms.
- To identify the knowledge gaps hindering the development of novel therapeutic strategies for cardiovascular diseases.
Main Methods:
- Review of current literature on catecholamine signaling and adrenergic receptor function in the cardiovascular system.
- Analysis of studies investigating the contribution of AR subtypes to cardiac remodeling, oxidative stress, and cell death.
- Synthesis of information on the interplay between AR signaling and cellular survival pathways.
Main Results:
- AR signaling is complex, with different subtypes mediating distinct effects on the heart.
- Prolonged CA exposure through AR activation contributes to oxidative stress and cellular dysfunction.
- Specific roles of α1AR and βAR in cardiac remodeling and cell death pathways are critical but not fully understood.
Conclusions:
- A deeper understanding of AR signaling complexity is fundamental for addressing catecholamine-induced cardiovascular damage.
- Targeting specific AR pathways may offer potential therapeutic avenues for heart failure.
- Further research is needed to bridge the knowledge gap concerning ARs, oxidative stress, and cell death in cardiovascular disease.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
Regulation of the Unfolded Protein Response
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
The Intrinsic Apoptotic Pathway
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...